Quick Links: Skip to main page content
Skip to Search
Skip to Topics Menu
Skip to Common Links
U.S. Food & Drug Administration
Follow FDA
En Español
Search FDA
Home
Food
Drugs
Medical Devices
Radiation-Emitting Products
Vaccines, Blood & Biologics
Animal & Veterinary
Cosmetics
Tobacco Products
New Pediatric Labeling Information Database - Detail
FDA Home
Pediatrics
New Pediatric Labeling Information Database
Detail
-
Please note:
JavaScript must be enabled for this application to work properly.
Check your settings
if you are unsure if your JavaScript is enabled.
Pediatric Labeling Date:
01/19/2011
Trade Name:
Nasonex
Generic Name or Proper Name (*):
mometasone
Indications Studied:
Treatment of nasal polyps
Label Changes Summary:
Safety and effectiveness for the treatment of nasal polyps in children < 18 years have not been establishedA trial in pediatric patients 6 to 17 years did not support the efficacy of Nasonex Nasal Spray in the treatment of nasal polyps The adverse events were similar to adultsInformation on clinical tria
Product Labeling:
Labeling
PREA(P):
P
Sponsor:
Schering Plough
NNPS:
TRUE'
Therapeutic Category:
Anti-inflammatory, topical
-
-